Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single-center Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00756509
What this trial is testing

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT03662399
What this trial is testing

Francis Biomechanics Study

Who this might be right for
Healthy Subject
Reckitt Benckiser Healthcare (UK) Limited 24
Early research (Phase 1)Ended earlyNCT00473616
What this trial is testing

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Who this might be right for
Advanced Solid TumorsCancerAdvanced Solid Malignancies
AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT07594236
What this trial is testing

Phase 1 Study of C.001 in Retinal Degeneration

Who this might be right for
Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more
Cellio Therapeutics Inc 15
Early research (Phase 1)Looking for participantsNCT07777484
What this trial is testing

An Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001 Vaccination.

Who this might be right for
Parkinson's Disease
Tridem Bioscience FlexCo 6
Not applicableLooking for participantsNCT05876000
What this trial is testing

Corheart 6 LVAS Study

Who this might be right for
Refractory Heart Failure
Shenzhen Core Medical Technology CO.,LTD. 53
Early research (Phase 1)Study completedNCT00504907
What this trial is testing

Safety Study of Oral BTA9881 to Treat RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Biota Scientific Management Pty Ltd 63
Early research (Phase 1)Study completedNCT02793466
What this trial is testing

Durvalumab in Pediatric and Adolescent Patients

Who this might be right for
Solid TumorLymphomaCentral Nervous System Tumors
Leo Mascarenhas 15
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Early research (Phase 1)Study completedNCT00419172
What this trial is testing

Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers

Who this might be right for
Healthy
Novartis 22
Post-approval studies (Phase 4)Study completedNCT00174330
What this trial is testing

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

Who this might be right for
HypertensionHyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330
Early research (Phase 1)Study completedNCT06822166
What this trial is testing

Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

Who this might be right for
Interaction Drug Food
Ahon Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)WithdrawnNCT00967512
What this trial is testing

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Who this might be right for
Acute Myelogenous Leukemia
Eleos, Inc.
Not applicableStudy completedNCT04161183
What this trial is testing

Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB)

Who this might be right for
Detrusor, UnderactiveDetrusor Underactivity
Chang Gung Memorial Hospital 11
Testing effectiveness (Phase 2)UnknownNCT06152822
What this trial is testing

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Who this might be right for
Breast Cancer With Brain Metastases
Tongji Hospital 30
Not applicableStudy completedNCT05302102
What this trial is testing

Unilateral Versus Bilateral Lower-Limb Plyometric Training in Children With Cerebral Palsy

Who this might be right for
Cerebral Palsy
Cairo University 69
Very early researchLooking for participantsNCT07656753
What this trial is testing

Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy

Who this might be right for
Inherited Retinal DystrophyInherited Retinal Disease
Peking Union Medical College Hospital 6
Early research (Phase 1)Study completedNCT00986895
What this trial is testing

Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Who this might be right for
Hepatic EncephalopathyUrea Cycle Disorders
Amgen 32
Not applicableStudy completedNCT03717519
What this trial is testing

Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases

Who this might be right for
Colorectal CancerColorectal CarcinomaStage IV Colon Cancer
Azienda Ospedaliera Universitaria Integrata Verona 196
Testing effectiveness (Phase 2)Study completedNCT04995419
What this trial is testing

Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy

Who this might be right for
Metastatic Urothelial Cancer
Astellas Pharma China, Inc. 40
Next Page